Dynamic Magnetic Resonance Imaging in Breast Cancer

  • Mei-Lin W. Ah-See
  • Anwar R. Padhani
Part of the Medical Radiology book series (MEDRAD)


Breast Cancer Breast Lesion Invasive Lobular Carcinoma Magn Reson Image Mean Transit Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham DC, Jones RC, Jones SE, et al. (1996) Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78: 91–100CrossRefPubMedGoogle Scholar
  2. Adams J, Carder PJ, Downey S, et al. (2000) Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 60: 2898–2905PubMedGoogle Scholar
  3. Ah-See MW, Makris A, Taylor NJ, et al. (2004) Does vascular imaging with MRI predict response to neoadjuvant chemotherapy in primary breast cancer. Meeting Proceedings of American Society of Clinical Oncology Vol. 23: 22, abstract 582Google Scholar
  4. Ah-See MW, Makris A, Taylor NJ, et al. (2003) Multifunctional magnetic resonance imaging predicts for clinicopathological response to neoadjuvant chemotherapy in primary breast cancer. In: 26th Annual San Antonio Breast Cancer Symposium, San Antonio, p 252Google Scholar
  5. Allen SA, Cunliffe WJ, Gray J, et al. (2001) Pre-operative estimation of primary breast cancer size: a comparison of clinical assessment, mammography and ultrasound. Breast 10: 299–305CrossRefPubMedGoogle Scholar
  6. Barbier EL, Lamalle L, Decorps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13:496–520CrossRefPubMedGoogle Scholar
  7. Bedrosian I, Schlencker J, Spitz FR, et al. (2002) Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions. Ann Surg Oncol 9:457–461CrossRefPubMedGoogle Scholar
  8. Belli P, Costantini M, Romani M, et al. (2002) Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat 73: 223–235CrossRefPubMedGoogle Scholar
  9. Bernsen HJ, Rijken PF, Peters JP, et al. (1998) Delayed vascular changes after antiangiogenic therapy with anti-vascular endothelial growth factor antibodies in human glioma xenografts in nude mice. Neurosurgery 43: 570–575; discussion 575–576CrossRefPubMedGoogle Scholar
  10. Bjurstam N, Bjorneld L, Warwick J, et al. (2003) The Gothenburg Breast Screening Trial. Cancer 97: 2387–2396CrossRefPubMedGoogle Scholar
  11. Boetes C, Barentsz JO, Mus RD, et al. (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193: 777–781PubMedGoogle Scholar
  12. Boetes C, Mus RD, Holland R, et al. (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197: 743–747PubMedGoogle Scholar
  13. Bonadonna G, Valagussa P, Brambilla C, et al. (1998) Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 16:93–100PubMedGoogle Scholar
  14. Bonadonna G, Veronesi U, Brambilla C, et al. (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539–1545PubMedGoogle Scholar
  15. Bose S, Lesser ML, Norton L, et al. (1996) Immunophenotype of intraductal carcinoma. Arch Pathol Lab Med 120:81–85PubMedGoogle Scholar
  16. Boyages J, Bilous M, Barraclough B, et al. (1988) Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother Oncol 13: 69–74PubMedGoogle Scholar
  17. Brekelmans CT, Seynaeve C, Bartels CC, et al. (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19: 924–930PubMedGoogle Scholar
  18. Brown J, Coulthard A, Dixon AK, et al. (2000) Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast 9: 78–82CrossRefPubMedGoogle Scholar
  19. Bruening R, Berchtenbreiter C, Holzknecht N, et al. (2000) Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study. AJNR Am J Neuroradiol 21: 1603–1610PubMedGoogle Scholar
  20. Buadu LD, Murakami J, Murayama S, et al. (1996) Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200: 639–649PubMedGoogle Scholar
  21. Buckley DL, Drew PJ, Mussurakis S, et al. (1997) Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 7: 461–464PubMedGoogle Scholar
  22. Burcombe RJ, Makris A, Davies C, et al. (2002) Vascular endothelial growth factor (VEGF) fails to predict response to neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res Treat 76: S122 abstract 475Google Scholar
  23. Ciatto S, Grazzini G, Iossa A, et al. (1990) In situ ductal carcinoma of the breast—analysis of clinical presentation and outcome in 156 consecutive cases. Eur J Surg Oncol 16:220–224PubMedGoogle Scholar
  24. Clarke D, Curtis JL, Martinez A, et al. (1983) Fat necrosis of the breast simulating recurrent carcinoma after primary radiotherapy in the management of early stage breast carcinoma. Cancer 52: 442–445PubMedGoogle Scholar
  25. Crystal P, Strano SD, Shcharynski S, et al. (2003) Using sonography to screen women with mammographically dense breasts. AJR Am J Roentgenol 181: 177–182PubMedGoogle Scholar
  26. Dao TH, Rahmouni A, Campana F, et al. (1993) Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187: 751–755PubMedGoogle Scholar
  27. D'Arcy J, Collins D, Padhani A, et al. (2004) Magnetic Resonance Imaging Workbench (MRIW): Dynamic contrast enhanced MRI data analysis and visualisation. Radiographics-submittedGoogle Scholar
  28. Darland DC, D'Amore PA (1999) Blood vessel maturation: vascular development comes of age. J Clin Invest 103:157–158PubMedGoogle Scholar
  29. Davis PL, Staiger MJ, Harris KB, et al. (1996) Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 37: 1–9CrossRefGoogle Scholar
  30. Delille JP, Slanetz PJ, Yeh ED, et al. (2003) Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 228: 63–69PubMedGoogle Scholar
  31. den Boer JA, Hoenderop RK, Smink J, et al. (1997) Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 7: 702–715PubMedGoogle Scholar
  32. Deniz K, O'Mahony S, Ross G, et al. (2003) Breast cancer in women after treatment for Hodgkin's disease. Lancet Oncol 4: 207–214PubMedGoogle Scholar
  33. Dennie J, Mandeville JB, Boxerman JL, et al. (1998) NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40: 793–799PubMedGoogle Scholar
  34. Denton ER, Sonoda LI, Rueckert D, et al. (1999) Comparison and evaluation of rigid, affine, and nonrigid registration of breast MR images. J Comput Assist Tomogr 23:800–805CrossRefPubMedGoogle Scholar
  35. Diekmann F, Diekmann S, Beljavskaja M, et al. (2004) [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 176: 544–549CrossRefPubMedGoogle Scholar
  36. Drew PJ, Chatterjee S, Turnbull LW, et al. (1999) Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 6: 599–603PubMedGoogle Scholar
  37. Drew PJ, Kerin MJ, Mahapatra T, et al. (2001) Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 27: 617–620CrossRefPubMedGoogle Scholar
  38. Drew PJ, Kerin MJ, Turnbull LW, et al. (1998) Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol 5: 265–270PubMedGoogle Scholar
  39. Ellerbroek N, Holmes F, Singletary E, et al. (1990) Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 66: 1461–1467PubMedGoogle Scholar
  40. Esserman L, Hylton N, Yassa L, et al. (1999) Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17: 110–119PubMedGoogle Scholar
  41. Esserman L, Kaplan E, Partridge S, et al. (2001) MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8: 549–559PubMedGoogle Scholar
  42. Evelhoch JL (1999) Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10: 254–259CrossRefPubMedGoogle Scholar
  43. Feldman LD, Hortobagyi GN, Buzdar AU, et al. (1986) Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578–2581PubMedGoogle Scholar
  44. Fiorentino C, Berruti A, Bottini A, et al. (2001) Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat 69: 143–151CrossRefPubMedGoogle Scholar
  45. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213: 881–888PubMedGoogle Scholar
  46. Fisher B, Anderson S, Bryant J, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241CrossRefPubMedGoogle Scholar
  47. Fisher B, Bryant J, Wolmark N, et al. (1998a) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672–2685PubMedGoogle Scholar
  48. Fisher B, Costantino JP, Wickerham DL, et al. (1998b) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371–1388CrossRefPubMedGoogle Scholar
  49. Fitzgibbons PL, Page DL, Weaver D, et al. (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966–978PubMedGoogle Scholar
  50. Flickinger FW, Allison JD, Sherry RM, et al. (1993) Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging 11: 617–620CrossRefPubMedGoogle Scholar
  51. Fobben ES, Rubin CZ, Kalisher L, et al. (1995) Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 196: 143–152PubMedGoogle Scholar
  52. Folkman J (1996) New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 32A: 2534–2539CrossRefPubMedGoogle Scholar
  53. Fortunato L, Sorrento JJ, Golub RA, et al. (1992) Occult breast cancer. A case report and review of the literature. N Y State J Med 92: 555–557PubMedGoogle Scholar
  54. Fourquet A, De La Rochefordiere A, Campana F (1996) Occult primary cancer with axillary metastases. In: Harris JR LM, Morrow M, Hellman S (Eds) (ed) Diseases of the breast. Lippincott-Raven, Philadelphia, Pa, pp 892–896Google Scholar
  55. Fox SB (1997) Tumour angiogenesis and prognosis. Histopathology 30: 294–301CrossRefPubMedGoogle Scholar
  56. Fox SB, Leek RD, Weekes MP, et al. (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275–283CrossRefPubMedGoogle Scholar
  57. Gasparini G, Toi M, Gion M, et al. (1997) Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89:139–147CrossRefPubMedGoogle Scholar
  58. Gilles R, Guinebretiere JM, Shapeero LG, et al. (1993) Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 188: 473–478PubMedGoogle Scholar
  59. Gilles R, Guinebretiere JM, Toussaint C, et al. (1994) Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 191: 633–638PubMedGoogle Scholar
  60. Gilles R, Zafrani B, Guinebretiere JM, et al. (1995) Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 196: 415–419PubMedGoogle Scholar
  61. Gribbestad IS, Nilsen G, Fjosne HE, et al. (1994) Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 4: 477–480PubMedGoogle Scholar
  62. Harms SE (2001) Integration of breast MRI in clinical trials. J Magn Reson Imaging 13: 830–836CrossRefPubMedGoogle Scholar
  63. Harms SE, Flamig DP, Hesley KL, et al. (1993) MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187: 493–501PubMedGoogle Scholar
  64. Hartmann LC, Schaid DJ, Woods JE, et al. (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340: 77–84CrossRefPubMedGoogle Scholar
  65. Hasan J, Byers R, Jayson GC (2002) Intra-tumoural microvessel density in human solid tumours. Br J Cancer 86: 1566–1577CrossRefPubMedGoogle Scholar
  66. Hayes C, Padhani AR, Leach MO (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15: 154–163CrossRefPubMedGoogle Scholar
  67. Helvie MA, Joynt LK, Cody RL, et al. (1996) Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198: 327–332PubMedGoogle Scholar
  68. Herrada J, Iyer RB, Atkinson EN, et al. (1997) Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 3: 1565–1569PubMedGoogle Scholar
  69. Heywang SH, Hilbertz T, Beck R, et al. (1990) Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 14: 348–356PubMedGoogle Scholar
  70. Heywang SH, Wolf A, Pruss E, et al. (1989) MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 171: 95–103PubMedGoogle Scholar
  71. Heywang-Kobrunner SH, Haustein J, Pohl C, et al. (1994) Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 191: 639–646PubMedGoogle Scholar
  72. Heywang-Kobrunner SH, Schlegel A, Beck R, et al. (1993) Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 17:891–900PubMedGoogle Scholar
  73. Holland R, Hendriks JH, Vebeek AL, et al. (1990) Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335: 519–522CrossRefPubMedGoogle Scholar
  74. Homer MJ (1991) Mammographic interpretation: a practical approach. New York, NY: McGraw-Hill 4–5Google Scholar
  75. Hulka CA, Edmister WB, Smith BL, et al. (1997) Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205: 837–842PubMedGoogle Scholar
  76. Ikeda DM, Hylton NM, Kinkel K, et al. (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13: 889–895CrossRefPubMedGoogle Scholar
  77. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9: 685–693CrossRefPubMedGoogle Scholar
  78. Jitsuiki Y, Hasebe T, Tsuda H, et al. (1999) Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. Mod Pathol 12: 492–498PubMedGoogle Scholar
  79. Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170: 681–686PubMedGoogle Scholar
  80. Kaufmann M, von Minckwitz G, Smith R, et al. (2003) International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J Clin Oncol 21: 2600–2608CrossRefPubMedGoogle Scholar
  81. Kerbel RS, Klement G, Pritchard KI, et al. (2002) Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic. Ann Oncol 13: 12–15CrossRefPubMedGoogle Scholar
  82. Kerslake RW, Fox JN, Carleton PJ, et al. (1994) Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. Br J Radiol 67: 1158–1168PubMedGoogle Scholar
  83. King MC, Wieand S, Hale K, et al. (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. Jama 286: 2251–2256CrossRefPubMedGoogle Scholar
  84. Knapper WH (1991) Management of occult breast cancer presenting as an axillary metastasis. Semin Surg Oncol 7: 311–313PubMedGoogle Scholar
  85. Knopp MV, Bourne MW, Sardanelli F, et al. (2003) Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol 181: 663–676PubMedGoogle Scholar
  86. Knopp MV, Brix G, Junkermann HJ, et al. (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 2: 633–658PubMedGoogle Scholar
  87. Knopp MV, Weiss E, Sinn HP, et al. (1999) Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10: 260–266CrossRefPubMedGoogle Scholar
  88. Kräer S, Schulz-Wendtland R, Hagedorn K, et al. (1998) Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer. Anticancer Res 18:2163–2164PubMedGoogle Scholar
  89. Kriege M, Brekelmans CT, Boetes C, et al. (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351: 427–437CrossRefPubMedGoogle Scholar
  90. Krishnamurthy R, Whitman GJ, Stelling CB, et al. (1999) Mammographic findings after breast conservation therapy. Radiographics 19 Spec No: S53–62; quiz S262–263PubMedGoogle Scholar
  91. Kuhl CK, Bieling H, Gieseke J, et al. (1997a) Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology 202: 87–95PubMedGoogle Scholar
  92. Kuhl CK, Bieling HB, Gieseke J, et al. (1997b) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203: 137–144PubMedGoogle Scholar
  93. Kuhl CK, Mielcareck P, Klaschik S, et al. (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211: 101–110PubMedGoogle Scholar
  94. Kuhl CK, Schmutzler RK, Leutner CC, et al. (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215: 267–279PubMedGoogle Scholar
  95. Kurtz JM, Amalric R, Brandone H, et al. (1988) Results of salvage surgery for mammary recurrence following breast-conserving therapy. Ann Surg 207: 347–351PubMedGoogle Scholar
  96. Kvistad KA, Lundgren S, Fjosne HE, et al. (1999) Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging. Acta Radiol 40: 45–51PubMedGoogle Scholar
  97. Lantzsch T, Hefler L, Krause U, et al. (2002) The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. Anticancer Res 22:1925–1928PubMedGoogle Scholar
  98. Lee SG, Orel SG, Woo IJ, et al. (2003) MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226:773–778PubMedGoogle Scholar
  99. Lewis-Jones HG, Whitehouse GH, Leinster SJ (1991) The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol 43: 197–204CrossRefPubMedGoogle Scholar
  100. Liberman L, Morris EA, Dershaw DD, et al. (2003a) Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol 181: 519–525PubMedGoogle Scholar
  101. Liberman L, Morris EA, Dershaw DD, et al. (2003b) MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180:901–910PubMedGoogle Scholar
  102. Liberman L, Morris EA, Kim CM, et al. (2003c) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180: 333–341PubMedGoogle Scholar
  103. Liberman L, Morris EA, Lee MJ, et al. (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179: 171–178PubMedGoogle Scholar
  104. Linderholm B, Lindh B, Tavelin B, et al. (2000) p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 89: 51–62CrossRefPubMedGoogle Scholar
  105. Lissoni P, Fugamalli E, Malugani F, et al. (2000) Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer. Int J Biol Markers 15: 308–311PubMedGoogle Scholar
  106. Liu PF, Debatin JF, Caduff RF, et al. (1998) Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 71: 501–509PubMedGoogle Scholar
  107. Liu YJ, Chung HW, Huang IJ, et al. (2002) A reinvestigation of maximal signal drop in dynamic susceptibility contrast magnetic resonance imaging. J Neuroimaging 12:330–338PubMedGoogle Scholar
  108. Makris A, Powles TJ, Ashley SE, et al. (1998) A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 9: 1179–1184CrossRefPubMedGoogle Scholar
  109. Makris A, Powles TJ, Kakolyris S, et al. (1999) Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma. Cancer 85:1996–2000PubMedGoogle Scholar
  110. Mandelson MT, Oestreicher N, Porter PL, et al. (2000) Breast density as a predictor of mammographic detection: comparison of interval-and screen-detected cancers. J Natl Cancer Inst 92: 1081–1087CrossRefPubMedGoogle Scholar
  111. Martincich L, Montemurro F, De Rosa G, et al. (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83: 67–76CrossRefPubMedGoogle Scholar
  112. Matsubayashi R, Matsuo Y, Edakuni G, et al. (2000) Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 217: 841–848PubMedGoogle Scholar
  113. Morris EA (2002) Breast cancer imaging with MRI. Radiol Clin North Am 40: 443–466CrossRefPubMedGoogle Scholar
  114. Mumtaz H, Davidson T, Hall-Craggs MA, et al. (1997a) Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer. Br J Surg 84: 1147–1151CrossRefPubMedGoogle Scholar
  115. Mumtaz H, Hall-Craggs MA, Davidson T, et al. (1997b) Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169: 417–424PubMedGoogle Scholar
  116. Murray AD, Redpath TW, Needham G, et al. (1996) Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma. Br J Radiol 69: 594–600PubMedGoogle Scholar
  117. Mussurakis S, Buckley DL, Bowsley SJ, et al. (1995) Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Invest Radiol 30: 650–662PubMedGoogle Scholar
  118. Muüller RD, Barkhausen J, Sauerwein W, et al. (1998) Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr 22: 408–412CrossRefPubMedGoogle Scholar
  119. Neubauer H, Li M, Kuehne-Heid R, et al. (2003) High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 76: 3–12CrossRefPubMedGoogle Scholar
  120. Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, et al. (2002) BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. Int J Radiat Biol 78: 285–295CrossRefPubMedGoogle Scholar
  121. Olson JA, Jr., Morris EA, Van Zee KJ, et al. (2000) Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 7: 411–415CrossRefPubMedGoogle Scholar
  122. Orel SG, Mendonca MH, Reynolds C, et al. (1997) MR imaging of ductal carcinoma in situ. Radiology 202: 413–420PubMedGoogle Scholar
  123. Orel SG, Schnall MD (2001) MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220: 13–30PubMedGoogle Scholar
  124. Orel SG, Schnall MD, LiVolsi VA, et al. (1994) Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 190: 485–493PubMedGoogle Scholar
  125. Orel SG, Schnall MD, Powell CM, et al. (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196: 115–122PubMedGoogle Scholar
  126. Orel SG, Troupin RH, Patterson EA, et al. (1992) Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection. Radiology 183: 201–206PubMedGoogle Scholar
  127. Orel SG, Weinstein SP, Schnall MD, et al. (1999) Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212: 543–549PubMedGoogle Scholar
  128. Osborne MP, Borgen PI, Wong GY, et al. (1992) Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy. Surg Gynecol Obstet 174: 189–194PubMedGoogle Scholar
  129. Ostergaard L, Sorensen AG, Kwong KK, et al. (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 36: 726–736PubMedGoogle Scholar
  130. Padhani A, Yarnold J, Regan J, et al. (2002) Magnetic resonance imaging of induration in the irradiated breast. Radiother Oncol 64: 157CrossRefPubMedGoogle Scholar
  131. Padhani AR, Dzik-Jurasz A (2004) Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging 15: 41–57CrossRefPubMedGoogle Scholar
  132. Padhani AR, Yarnold J, Regan J, et al. (2003) Dynamic MRI of breast hardness following radiation treatment. J Magn Reson Imaging 17: 427–434CrossRefPubMedGoogle Scholar
  133. Pain JA, Ebbs SR, Hern RP, et al. (1992) Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol 18: 44–48PubMedGoogle Scholar
  134. Parker GJ, Baustert I, Tanner SF, et al. (2000) Improving image quality and T(1) measurements using saturation recovery turboFLASH with an approximate K-space normalisation filter. Magn Reson Imaging 18: 157–167CrossRefPubMedGoogle Scholar
  135. Parker GJ, Suckling J, Tanner SF, et al. (1997) Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 7: 564–574PubMedGoogle Scholar
  136. Paulus DD (1984) Conservative treatment of breast cancer: mammography in patient selection and follow-up. AJR Am J Roentgenol 143: 483–487PubMedGoogle Scholar
  137. Pierce WB, Harms SE, Flamig DP, et al. (1991) Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress. Radiology 181: 757–763PubMedGoogle Scholar
  138. Podo F, Sardanelli F, Canese R, et al. (2002a) The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. In: J Exp Clin Cancer Res, vol 21, pp 115–124Google Scholar
  139. Podo F, Sardanelli F, Canese R, et al. (2002b) The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 21:115–124Google Scholar
  140. Pritt B, Ashikaga T, Oppenheimer RG, et al. (2004) Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod PatholGoogle Scholar
  141. Qayyum A, Birdwell RL, Daniel BL, et al. (2002) MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 178:1227–1232PubMedGoogle Scholar
  142. Rak JW, St Croix BD, Kerbel RS (1995) Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 6: 3–18Google Scholar
  143. Rebbeck TR, Friebel T, Lynch HT, et al. (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22: 1055–1062CrossRefPubMedGoogle Scholar
  144. Rebbeck TR, Levin AM, Eisen A, et al. (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91: 1475–1479CrossRefPubMedGoogle Scholar
  145. Revel D, Brasch RC, Paajanen H, et al. (1986) Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology 158: 319–323PubMedGoogle Scholar
  146. Rieber A, Brambs HJ, Gabelmann A, et al. (2002) Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 12: 1711–1719CrossRefPubMedGoogle Scholar
  147. Ringberg A, Palmer B, Linell F (1982) The contralateral breast at reconstructive surgery after breast cancer operation—a histopathological study. Breast Cancer Res Treat 2: 151–161CrossRefPubMedGoogle Scholar
  148. Roberts TP (1997) Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 7: 82–90PubMedGoogle Scholar
  149. Rosen BR, Belliveau JW, Buchbinder BR, et al. (1991) Contrast agents and cerebral hemodynamics. Magn Reson Med 19: 285–292PubMedGoogle Scholar
  150. Rosen PP, Kimmel M (1990) Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 21: 518–523CrossRefPubMedGoogle Scholar
  151. Rosen PP, Senie R, Schottenfeld D, et al. (1979) Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 189: 377–382PubMedGoogle Scholar
  152. Rostom AY, el-Sayed ME (1987) Fat necrosis of the breast: an unusual complication of lumpectomy and radiotherapy in breast cancer. Clin Radiol 38: 31CrossRefPubMedGoogle Scholar
  153. Schnall MD, Ikeda DM (1999) Lesion Diagnosis Working Group report. J Magn Reson Imaging 10: 982–990CrossRefPubMedGoogle Scholar
  154. Schorn C, Fischer U, Luftner-Nagel S, et al. (1999) MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 9: 470–473CrossRefPubMedGoogle Scholar
  155. Senger DR, Galli SJ, Dvorak AM, et al. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983–985PubMedGoogle Scholar
  156. Sickles EA, Herzog KA (1981) Mammography of the postsurgical breast. AJR Am J Roentgenol 136: 585–588PubMedGoogle Scholar
  157. Siegmann KC, Muller-Schimpfle M, Schick F, et al. (2002) MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol 178: 1403–1409PubMedGoogle Scholar
  158. Slanetz PJ, Edmister WB, Yeh ED, et al. (2002) Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 8: 145–148CrossRefPubMedGoogle Scholar
  159. Smith IC, Heys SD, Hutcheon AW, et al. (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20: 1456–1466CrossRefPubMedGoogle Scholar
  160. Snelling JD, Abdullah N, Brown G, et al. (2004) Measurement of tumour size in case selection for breast cancer therapy by clinical assessment and ultrasound. Eur J Surg Oncol 30: 5–9CrossRefPubMedGoogle Scholar
  161. Sorensen AG, Tievsky AL, Ostergaard L, et al. (1997) Contrast agents in functional MR imaging. J Magn Reson Imaging 7: 47–55PubMedGoogle Scholar
  162. Stomper PC, Herman S, Klippenstein DL, et al. (1995) Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197: 387–395PubMedGoogle Scholar
  163. Stomper PC, Recht A, Berenberg AL, et al. (1987) Mammographic detection of recurrent cancer in the irradiated breast. AJR Am J Roentgenol 148: 39–43PubMedGoogle Scholar
  164. Stomper PC, Winston JS, Herman S, et al. (1997) Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45: 39–46CrossRefPubMedGoogle Scholar
  165. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. (2001a) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. In: J Natl Cancer Inst, vol 93, pp 1095–1102.CrossRefPubMedGoogle Scholar
  166. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. (2001b) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93:1095–1102.CrossRefPubMedGoogle Scholar
  167. Su MY, Cheung YC, Fruehauf JP, et al. (2003) Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 18: 467–477CrossRefPubMedGoogle Scholar
  168. Takehara M, Tamura M, Kameda H, et al. (2004) Examination of breast conserving therapy in lobular carcinoma. Breast Cancer 11: 69–72PubMedGoogle Scholar
  169. Tan JE, Orel SG, Schnall MD, et al. (1999) Role of magnetic resonance imaging and magnetic resonance imaging—guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 22: 414–418CrossRefPubMedGoogle Scholar
  170. Teh W, Wilson AR (1998) The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer 34: 449–450CrossRefPubMedGoogle Scholar
  171. Thurfjell EL, Lindgren JA (1996) Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years. Radiology 201: 421–426PubMedGoogle Scholar
  172. Tilanus-Linthorst MM, Obdeijn AI, Bontenbal M, et al. (1997) MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat 44: 179–182CrossRefPubMedGoogle Scholar
  173. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, et al. (2000a) First experiences in screening women at high risk for breast cancer with MR imaging. In: Breast Cancer Res Treat, vol 63, pp 53–60.CrossRefPubMedGoogle Scholar
  174. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, et al. (2000b) First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63: 53–60.CrossRefPubMedGoogle Scholar
  175. Tofts PS (1997) Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7: 91–101PubMedGoogle Scholar
  176. Tofts PS, Berkowitz B, Schnall MD (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 33: 564–568PubMedGoogle Scholar
  177. Tofts PS, Brix G, Buckley DL, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMedGoogle Scholar
  178. Toi M, Inada K, Suzuki H, et al. (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193–204CrossRefPubMedGoogle Scholar
  179. Toi M, Matsumoto T, Bando H (2001) Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2: 667–673CrossRefPubMedGoogle Scholar
  180. van der Hage JA, van de Velde CJ, Julien JP, et al. (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19: 4224–4237PubMedGoogle Scholar
  181. van Dongen JA, Voogd AC, Fentiman IS, et al. (2000) Longterm results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92: 1143–1150CrossRefPubMedGoogle Scholar
  182. Vermeulen PB, Gasparini G, Fox SB, et al. (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564–1579CrossRefPubMedGoogle Scholar
  183. Vermeulen PB, Gasparini G, Fox SB, et al. (1996) Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474–2484CrossRefPubMedGoogle Scholar
  184. Veronesi U, Cascinelli N, Mariani L, et al. (2002) Twenty-year follow-up of a randomized study comparing breast-conserving conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227–1232CrossRefPubMedGoogle Scholar
  185. Viehweg P, Heinig A, Lampe D, et al. (1998) Retrospective analysis for evaluation of the value of contrast-enhanced MRI in patients treated with breast conservative therapy. Magma 7: 141–152PubMedGoogle Scholar
  186. Vinnicombe SJ, MacVicar AD, Guy RL, et al. (1996) Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 198: 333–340PubMedGoogle Scholar
  187. Warner E, Plewes DB, Shumak RS, et al. (2001a) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. In: J Clin Oncol, vol 19, pp 3524–3531.PubMedGoogle Scholar
  188. Warner E, Plewes DB, Shumak RS, et al. (2001b) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19: 3524–3531.PubMedGoogle Scholar
  189. Warren R (2001) Is breast MRI mature enough to be recommended for general use? Lancet 358: 1745–1746.CrossRefPubMedGoogle Scholar
  190. Weatherall PT, Evans GF, Metzger GJ, et al. (2001) MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 13: 868–875CrossRefPubMedGoogle Scholar
  191. Weidner N (1998) Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119–122CrossRefPubMedGoogle Scholar
  192. Weind KL, Maier CF, Rutt BK, et al. (1998) Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions—implications for imaging modalities. Radiology 208: 477–483PubMedGoogle Scholar
  193. Whitehouse GH, Moore NR (1994) MR imaging of the breast after surgery for breast cancer. Magn Reson Imaging Clin N Am 2: 591–603PubMedGoogle Scholar
  194. Yang WT, Lam WW, Cheung H, et al. (1997) Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 16: 791–797PubMedGoogle Scholar
  195. Yeh ED, Slanetz PJ, Edmister WB, et al. (2003) Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging. Breast J 9: 13–18CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Mei-Lin W. Ah-See
    • 1
  • Anwar R. Padhani
    • 1
  1. 1.Paul Strickland Scanner CentreMount Vernon HospitalNorthwood, MiddlesexUK

Personalised recommendations